Premaitha Health Share Price (NIPT)

0.00 0.00 (0.00%) delayed: 4:38AM BST
Bid price 9.00 Open price 0.00
Ask price 9.30 Prev close 9.25
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Premaitha Health share prices, Premaitha Health stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Premaitha Health Level 2 Data, indepth research tools and investor commentary for Premaitha Health (NIPT) and other London Stock Exchange equities.

Premaitha Health Share Price Chart

Advanced Charts >>

Register now for FREE Premaitha Health share price charts

Premaitha Health Share Price Information

Name Premaitha Health Epic NIPT
Sector Pharmaceuticals & Biotechnology ISIN GB00BN31ZD89
Activites Premaitha Health plc (formerly ViaLogy plc, formerly Original Investments plc, formerly Bioprojects International plc) is an international molecular diagnostics group which uses the latest advances in DNA analysis technology to develop safer, faster and regulatory approved genetic screening tests. The Group's primary focus is on non-invasive prenatal tests (NIPT) for pregnant women - an emerging, multi-billion dollar global market. Premaitha's IONA test was launched in 2015 as the first CE-IVD NIPT test in Europe. It enables laboratories and healthcare practitioners to offer a complete CE-marked NIPT system in-house. The IONA® test is performed on a maternal blood sample - which contains traces of fetal DNA - and estimates the risk of a fetus being affected with Down's syndrome or other genetic conditions. Index n/a

Premaitha Health Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 115.88
Market Capitalisation (£m) 38.56 Gross Gearing (%) 117.82
Shares in issue (m) 416.84 Debt Ratio 126.13
P/E Ratio -3.08 Debt-to-Equity Ratio 0.73
Total dividends per share (p) 0.00 Assets / Equity Ratio -5.61
Dividend Yield (%) 0.00 Price to book value -14.83
Dividend cover (x) 0.00 ROCE (%) -95.88
Earning per share (p) -3.00 EPS Growth (%) 0.00
52 week high / low 15.75 / 3.75 DPS Growth (%) n/a

Premaitha Health Director Deals

Dec.Date Type Director Pos No. of Shares
05/10/2018 BUY Barry Hextall FD 100,000
18/12/2015 BUY Barry Hextall FD 180,736

More Premaitha Health Director Deals >>

Premaitha Health Company News

08:13 22/10/2018

Premaitha Health confirms increase in share issuance

Molecular diagnostics group Premaitha Health confirmed it had increased the size of a share issuance to around £2.1m. A second tranche admission of new shares was increased to around 21.0m placing shares from around 20.2 placing shares, the company said. Admission of the new shares was expected...

07:00 22/10/2018

Further re: Fundraise

RNS Number : 6812E Premaitha Health PLC 22 October 2018   Premaitha Health PLC ("Premaitha," the "Company" or the "Group")   Further re: Fundraise   Manchester, UK - 22 October 2018:  Premaitha (AIM: NIPT), a leading international molecular diagnostics...

13:15 12/10/2018

Availability of Research Commentary

RNS Number : 9261D Premaitha Health PLC 12 October 2018   Premaitha Health plc ("Premaitha" or the "Group")   Availability of Research Commentary   Manchester, UK - 12 October 2018 : Premaitha Health plc (AIM: NIPT), a leading international molecular...

More Premaitha Health Company News >>

Register now for FREE Premaitha Health company news

Premaitha Health Share Price Discussions

more than 1 year ago

Premaitha Health - molecular diagnostics (NIPT)

Company Profile. Premaitha Health (Formerly ViaLogy PLC) is a molecular diagnostics company employing next generation DNA analysis technology to develop, manufacture and sell molecular diagnostic products intended to have a major beneficial impact on human health. Premaitha is responsible...

Register now for FREE Premaitha Health share price discussions